Key facts: Belgium
| Main buyers | Individual hospitals and loco-regional hospital networks; joint tenders between hospitals |
|---|---|
| Main routes | Hospital tenders by lot and framework agreements |
| Typical term | Biologicals at most 24 months plus two 12-month extensions; other frameworks up to four years |
| Award model | Multi-criteria, with price, quality and service; several criteria are banned for biologicals |
How do Belgian hospitals tender?
Hospitals have been grouping into loco-regional networks, and purchasing is following. Some networks and hospital pairs now tender jointly, which increases lot sizes and the stakes of each round.
Tender documents can be in French, Dutch or German depending on the buyer, so tracking Belgium properly means reading all three.
What changed for biosimilars in 2023?
A royal decree in force since 2 October 2023 obliges hospitals to tender a biological within nine months of the first reimbursed biosimilar, limits contracts to 24 months plus two one-year extensions, and bans criteria such as time on the market, unrelated services and volume discounts tied to patent-protected lots. Belgium's highest administrative court ruled in 2025 that biosimilars may not be favoured either.
How does RGS help in Belgium?
We monitor hospital and network tenders in all three languages, link each award to the buyer's network, and keep the calendar of biosimilar entries and contract ends, which shows rounds coming before they are published.
What is public in Belgium, and what is not
Tender notices and award notices with the winner and the contract value are published.
Unit prices are generally not. Confidential agreements with the national health insurer and negotiated purchases below the thresholds are not published, and outpatient generics are not tendered because their prices are set nationally.
Questions about Belgium
Who buys hospital medicines in Belgium?
Individual hospitals and, increasingly, the loco-regional hospital networks formed since 2020, some of which tender jointly.
When must a Belgian hospital tender a biological medicine?
Within nine months of the first reimbursed biosimilar, on a contract of at most 24 months plus two 12-month extensions.
Can RGS show confidential contracts and prices in Belgium?
No outside service can, because they are never published. RGS covers what buyers publish. For the confidential part we set up a private pipeline for your company: your own bids, results, buyer correspondence and price lists, loaded next to the public data and visible only to your team.